Biomarker Study of Acamprosate in Schizophrenia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Acamprosate (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 25 Sep 2019 Biomarkers information updated
- 01 Jun 2010 Planned number of patients changed from 40 to 50 as reported by ClinicalTrials.gov.
- 04 Nov 2009 Planned number of patients changed from 10 to 40 as reported by ClinicalTrials.gov.